Search Page
Save citations to file
Email citations
On or after July 28, sending email will require My NCBI login.
Learn more about this and other changes coming to the email feature.
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Differentiation-dependent EBF1 Activity Determines CD22 Transcription and Leukemia Sensitivity to Inotuzumab Ozogamicin.
Blood. 2025 May 28:blood.2024028215. doi: 10.1182/blood.2024028215. Online ahead of print.
Blood. 2025.
PMID: 40435412
DNTT-mediated DNA damage response drives inotuzumab ozogamicin resistance in B-cell acute lymphoblastic leukemia.
Escherich CS, Moriyama T, Li Z, Hsiao YC, Yang W, Li Y, Reyes N, Walker M, Budhraja A, Bhatara S, Diaz-Flores E, Stock W, Paietta E, Konopleva MY, Kornblau SM, Litzow MR, Inaba H, Pui CH, Opferman JT, Loh ML, Yu J, O'Brien MM, Evans WE, Yang JJ.
Escherich CS, et al.
Blood. 2025 Mar 13;145(11):1182-1194. doi: 10.1182/blood.2024026085.
Blood. 2025.
PMID: 39791601
Item in Clipboard
Germ line genetic NBN variation and predisposition to B-cell acute lymphoblastic leukemia in children.
Escherich CS, Chen W, Li Y, Yang W, Nishii R, Li Z, Raetz EA, Devidas M, Wu G, Nichols KE, Inaba H, Pui CH, Jeha S, Camitta BM, Larsen E, Hunger SP, Loh ML, Yang JJ.
Escherich CS, et al.
Blood. 2024 May 30;143(22):2270-2283. doi: 10.1182/blood.2023023336.
Blood. 2024.
PMID: 38446568
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.